Progyny envisions a world where anyone who wants to have a child can do so

That’s why we’re bringing new life to fertility benefits, for a new generation of companies. Our fertility solutions ensure employers receive the most value from their fertility benefit by enabling members and physicians to focus on outcomes and pursue the most effective treatment — the first time. When cutting-edge fertility science meets unparalleled member support, smarter fertility benefits are born. And dreams of parenthood come true.

Leadership

DAVID SCHLANGER
Chief Executive Officer

As Progyny’s CEO, David brings over 25 years of healthcare and executive management experience to the company. He strives to make Progyny the industry leader in comprehensive and inclusive fertility benefits–so people can achieve the best possible outcomes and realize their dreams of parenthood. Prior to joining Progyny, David was the CEO of WebMD, where he led the company to record levels of revenue and profitability.

PETER ANEVSKI
Chief Financial & Operating Officer

As the Chief Financial and Operating Officer, Pete brings over a decade of experience in building and implementing models that lead to operational efficiency and revenue growth. Pete is responsible for managing the company’s financial actions, building its premier provider network, and optimizing operations. Prior to joining Progyny, Pete was the CFO at WebMD where he played an integral role in the company’s improved financial performance.

KARIN AJMANI
President

Karin uses her public health and managed care experience to lead product development and sales for Progyny. She aims to expand employer adoption of infertility benefits, so everyone can achieve their dream of parenthood. Prior to joining Progyny, Karin was CEO of US Imaging, and previously served as CEO of CarePlus Health Plan. In 2017, Karin was selected as one of New York Business Journal’s Women of Influence.

Alan B. Copperman, MD, FACOG
Medical Director

As an experienced and respected clinician, Dr. Copperman has published numerous manuscripts and book chapters on reproductive medicine, and has co-authored hundreds of scientific abstracts on infertility, in vitro fertilization, egg freezing, ovum donation and genetics. Dr. Copperman has been named to New York magazine’s list of Best Doctors sixteen years in a row, and Castle Connolly and SuperDocs have annually recognized Dr. Copperman as one of the top fertility doctors.


Board of directors

David Schlanger
Chief Executive Officer
Beth Seidenberg, M.D.
Kleiner Perkins Caufield & Byers
Fred Cohen, M.D., D.Phil.
TPG Biotech
Norm Payson
Norman C. Payson, M.D.
Simeon George, M.D.
SR One

Progyny In The News

January 30, 2019
The New York Times
Progyny, a fertility benefits manager, is also streamlining fertility treatment and removing hurdles like the “trying naturally” commandments. Its clients, including Unilever, MassMutual, Viacom and Cerner, also pay for genetic screening of embryos, with a typical cost of about $5,000, which helps identify genetic diseases and the embryos that are most likely to lead to a miscarriage.

The New York Times
January 30, 2019
Slate
“A traditional health plan from a company that offers [what some would consider] ‘decent benefits’ though their health insurer would be a $20,000 lifetime maximum benefit. But it could have all these pre certification protocols where you might [have to do] three to six rounds of [intrauterine insemination] before they even let you try IVF, and at that point you’ve used up almost your entire benefit,” said David Schlanger, CEO of Progyny.

Slate
January 19, 2019
CNBC
David Schlanger, CEO of Progyny, discusses how women are waiting longer to have children.

CNBC
January 1, 2019
Romper
Dr. Alan Copperman, Medical Director at Progyny, shares a few tips on what you should do if you’re planning to conceive this year.

Romper
December 7, 2018
CNBC
David Schlanger, CEO of Progyny, discusses why companies should offer a fertility benefit and the difference with Progyny.

CNBC